Atlanta MedTech Startup Raises $10 Million Series A
A small but mighty team in Atlanta is tackling one of medicine’s biggest challenges: cutting postoperative pain while reducing opioid use.
Shyamy Sastry and his team at the medical device startup Synaptrix, Inc. have developed a proprietary system NOVABLOC™, which is looking to bring new options to the modern pain management world. Its human feasibility studies have demonstrated more than 20 days of pain relief with a single treatment.
The startup says it is “committed to reducing opioids” while bringing more user-friendly options to the pain management space.
“Modern day treatments for postoperative pain management are largely insufficient. They are either plagued by short-lasting pain control, limit physical rehabilitation, or invite opioid use,” said CEO Sastry. “The NOVABLOC™ system is a groundbreaking neuromodulation technology designed to deliver 20+ days of pain relief without impacting motor function or touch. Altogether, the system treats postoperative pain for days to weeks while promoting rehabilitation and reducing the need for opioids.”
As Sastry explained to Hypepotamus, neuromodulation is a “treatment that uses electrical or chemical stimulation to modify neural activity.” For NOVABLOC, that means delivering “electrical stimulation to selectively reduce neural activity transmitted by pain fibers.”
Keep Reading Here: https://hypepotamus.com/startup-news/synaptrix-raises-10-million/
